Safety and Tolerability of Relugolix in Combination with Abiraterone or Apalutamide for Treatment of Patients with Advanced Prostate Cancer: Data from a 52-Week Clinical Trial
Titel:
Safety and Tolerability of Relugolix in Combination with Abiraterone or Apalutamide for Treatment of Patients with Advanced Prostate Cancer: Data from a 52-Week Clinical Trial
Auteur:
De La Cerda, Jose Belkoff, Laurence Courtney, Kevin D. Diamond, Elan D’Olimpio, James Dunshee, Curtis Gervasi, Lawrence Goodman, Michael Mittal, Kriti Morris, David Sieber, Paul Tutrone, Ronald Ryan, Michael Zhong, Yi Ufer, Mike Shore, Neal